Ankylosing Spondylitis Market: Current Trends and Future Outlook


Symptoms and complications for many patients can be controlled or reduced by following a regular treatment plan. The early signs and symptoms of ankylosing spondylitis might include pain and stiffness in the lower back and hips, especially in the morning and after periods of inactivity. Neck pain and fatigue also are common. Over time, symptoms might worsen, improve or stop at irregular intervals.

The ankylosing spondylitis has no known specific cause, though genetic factors seem to be involved. In particular, people who have a gene called HLA-B27 are at a greatly increased risk of developing ankylosing spondylitis. However, only some people with the gene develop the condition. The ankylosing spondylitis can be diagnosed with physical examination. In addition, MRI and X-ray imaging tests are performed for diagnosis of ankylosing spondylitis.

The ankylosing spondylitis cannot be cured or treated completely but symptoms of disease can be managed with drug treatment and physical exercise. For the management of pain associated with ankylosing spondylitis generally NSAIDs are preferred. In addition, TNF inhibitors, corticosteroids and disease-modifying antirheumatic drugs (DMARDs) are used for management of inflammation in ankylosing spondylitis. Furthermore, monoclonal antibodies has been approved for treatment of ankylosing spondylitis.

The growth of the global ankylosing spondylitis market is majorly driven by an increase in prevalence of ankylosing spondylitis. For instance, according to paper published in Scandinavian Journal of Rheumatology, in 2020, titled ‘Prevalence of ankylosing spondylitis in Spain’, the study found that about 7.3% population shows positive screening for ankylosing spondylitis. Furthermore, rise in number of orthopedic hospitals and diagnostic centers boost the diagnosis and treatment of diseases. For instance, according to Definitive Healthcare data in 2020 there are more than 30,500 orthopedic surgeons in the U.S. 

Moreover, advancement in ankylosing spondylitis therapy is anticipated to contribute toward the growth of the ankylosing spondylitis market. For instance, in August, 2019, Lilly, a leading manufacturer of biopharmaceuticals, receives U.S. FDA Approval for Taltz (ixekizumab) for the Treatment of Active Ankylosing Spondylitis. Taltz is a monoclonal antibody used to reduce inflammation and pain. However, high cost of ankylosing spondylitis therapy and adverse effects of drugs used for treatment of ankylosing spondylitis restricted the market growth during the forecast period.

 

Read Our More Reports :  https://healthcarenewsbulletin.blogspot.com/2023/09/trends-and-opportunities-in-stretch.html

https://healthcarenewsbulletin.blogspot.com/2023/09/emerging-therapies-in-vernal.html

https://healthcarenewsbulletin.blogspot.com/2023/09/understanding-circadian-rhythm-sleep.html

https://healthcarenewsbulletin.blogspot.com/2023/09/market-dynamics-of-deep-brain.html


Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, d...
Read more

The Global Boat Accumulator Market Growth Is Accelerated By Increasing Consumer Spending

Image
  Boat accumulators or batteries are sealed lead acid batteries that provide starting power and deep cycle power for boats. They are essential for powering marine electrical systems, motors, navigation lights, bilge pumps and other onboard appliances. The growing marine tourism and recreational boating activities have increased the demand for boats and yachts over the years. This has propelled the boat accumulator market. The global Boat Accumulator Market is estimated to be valued at US$ 266.66 Mn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing consumer spending on recreational boating activities has been a major driver for the boat accumulator market over the past decade. The number of recreational boats sold globally has increased steadily with the rise in disposable incomes and leisure time among consumers. Countries like the United S...
Read more

Growth Accelerated by Rising Demand from Biomedical Research and Clinical Diagnostics

Image
  Chemiluminescence imaging is widely used technique for the detection of biomolecules. The technique offers advantages such as high sensitivity, minimal sample requirement and less incubation time. Chemiluminescence assays find wide application in various research areas such as oncology research, infectious disease research and reproductive health among others. Moreover, clinical diagnostics of conditions like cancer, liver disorders also rely on chemiluminescence technique for detection of biomarkers. Growing incidence of chronic diseases is propelling the demand for clinical diagnostic testing, thus favoring the growth of chemiluminescence imaging market. The global Chemiluminescence Imaging Market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Rising demand from biomedical research and clinical diagnos...
Read more